ArticleAnnals of the American Thoracic Society2023
Systemic Markers of Lung Function and Forced Expiratory Volume in 1 Second Decline across Diverse Cohorts.
Open access · greenAbstract read
In one paragraph
Article in Annals of the American Thoracic Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.
- Effect of radical resection of lung cancer combined with breathing training on lung cancer patients in thoracic surgery: a meta-analysis.BMC pulmonary medicine · 2025Pooled it
- Borderline Forced Expiratory Volume in 1 Second to Forced Vital Capacity and Low Forced Expiratory Volume in 1 Second Predict Disease Progression in High-Risk Populations With COPD.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2026Article
- Circulating proteomic landscape of lung function.The European respiratory journal · 2026Article
- Comorbidity of chronic obstructive pulmonary disease and pulmonary tuberculosis: a bibliometric analysis (2011-2025) with narrative review.Journal of thoracic disease · 2026Article
- Vascular-related proteomic signatures in COPD with suspected pulmonary hypertension as predictors of FEV₁ impairment.Respiratory research · 2026Article
- Proteomic Profiling of Pulmonary Function and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities Study.Journal of the American Heart Association · 2026Observational
- New approaches to uncover COPD pathobiology and develop therapies.JCI insight · 2026Review
- Proteomic biomarkers of long-term lung function decline in textile workers: a 35-year longitudinal study.Journal of exposure science & environmental epidemiology · 2025Article
- Evaluation of Kallistatin Levels in COPD Exacerbations.Canadian respiratory journal · 2025Article
- Proteomic Risk Score of Increased Respiratory Susceptibility: A Multicohort Study.American journal of respiratory and critical care medicine · 2025Article
- Dynamic and prognostic proteomic associations with FEVmedRxiv : the preprint server for health sciences · 2024Article
- Multiomics and Multiancestry Approaches: Key Steps to Untangling the Web of Chronic Obstructive Pulmonary Disease Pathogenesis.Annals of the American Thoracic Society · 2023Article
Corrections and comments
- Commented on by
Authors and funding
54 authors at 20 institutions in 6 countries.
Debby NgoCardiovascular Research Institute.ORCID 0000-0003-2681-3475
Katherine A PratteNational Jewish Health, Denver, Colorado.
Claudia FlexederInstitute of Epidemiology and.
Hans PetersenLovelace Respiratory Research Institute, Albuquerque, New Mexico.
Hong DangUniversity of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Yanlin MaCenter for Public Health Genomics, University of Virginia, Charlottesville, Virginia.
Michelle J KeyesCardiovascular Research Institute.
Yan GaoDepartment of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi; and.
Shuliang DengCardiovascular Research Institute.
Bennet D PetersonCardiovascular Research Institute.
Laurie A FarrellCardiovascular Research Institute.
Victoria M BhambhaniCardiovascular Research Institute.
Cesar PalaciosCardiovascular Research Institute.
Juweria QuadirCardiovascular Research Institute.
Lucas GillenwaterNational Jewish Health, Denver, Colorado.
Hanfei XuDepartment of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.
Claire EmsonTranslational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.
Christian GiegerInstitute of Epidemiology and.
Karsten SuhreDepartment of Physiology and Biophysics, Weill Cornell Medicine Qatar, Education City, Doha, Qatar.
Johannes GraumannPhilipps-Universität, Marburg, Germany.
Deepti JainDepartment of Biostatistics, University of Washington, Seattle, Washington.
Matthew P ConomosDepartment of Biostatistics, University of Washington, Seattle, Washington.
Russell P TracyDepartment of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, Vermont.
Xiuqing GuoThe Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA (University of California, Los Angeles) Medical Center, Torrance, California.
Yongmei LiuDivision of Cardiology, Duke Molecular Physiology Institute, Duke University Medical Center, Durham, North Carolina.
W Craig JohnsonDepartment of Biostatistics, University of Washington, Seattle, Washington.
Elaine CornellDepartment of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, Vermont.
Peter DurdaDepartment of Pathology and Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, Vermont.
Kent D TaylorThe Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA (University of California, Los Angeles) Medical Center, Torrance, California.
George J PapanicolaouNational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
Stephen S RichCenter for Public Health Genomics, University of Virginia, Charlottesville, Virginia.
Jerome I RotterThe Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA (University of California, Los Angeles) Medical Center, Torrance, California.
Steven I RennardPulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California.
Jeffrey L CurtisUniversity of Michigan, Ann Arbor, Michigan.
Prescott G WoodruffPulmonary, Critical Care, Allergy, and Sleep Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California.
Alejandro P ComellasUniversity of Iowa, Iowa City, Iowa.ORCID 0000-0003-1521-7520
Edwin K SilvermanChanning Division of Network Medicine, and.
James D CrapoNational Jewish Health, Denver, Colorado.
Martin G LarsonDepartment of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.
Ramachandran S VasanThe National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts.
Thomas J WangDepartment of Medicine, UT (University of Texas) Southwestern Medical Center, Dallas, Texas.
Adolfo CorreaJackson Heart Study, Department of Medicine, and.
Mario SimsJackson Heart Study, Department of Medicine, and.
James G WilsonCardiovascular Research Institute.
Robert E GersztenCardiovascular Research Institute.
George T O'ConnorThe National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts.
R Graham BarrDepartment of Medicine and.
David CouperUniversity of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Josée DupuisDepartment of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.
Ani ManichaikulCenter for Public Health Genomics, University of Virginia, Charlottesville, Virginia.
Wanda K O'NealUniversity of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Yohannes TesfaigziLovelace Respiratory Research Institute, Albuquerque, New Mexico.ORCID 0000-0002-3997-5839
Holger SchulzInstitute of Epidemiology and.
Russell P BowlerNational Jewish Health, Denver, Colorado.ORCID 0000-0003-4651-363X
Cardiovascular Institute Hospital · JPBoston University · USNational Jewish Health · USJackson Memorial Hospital · USUniversity of California, Los Angeles · USUniversity of North Carolina at Chapel Hill · USUniversity of Vermont · USUniversity of Virginia · USUniversity of Washington · USInstitute of Epidemiology, Disease Control and Research · BDUniversity of California, San Francisco · USAstraZeneca (United States) · USBeth Israel Deaconess Medical Center · USBrigham and Women's Hospital · USColumbia University · USDuke Medical Center · USHelmholtz Zentrum München · DELovelace Respiratory Research Institute · USNational Institutes of Health · USPhilipps University of Marburg · DE
Funding
Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5MMetabolomic signatures of empysema and COPD progression in the COPDGene cohortR01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2012 to 2016
$31.1MVector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Alejandro Antonio Pezzulo · 1998 to 2026
$30.5M(2 of 2) Genetic Epidemiology of COPDR01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2012 to 2016
$18.9MResolution of Epithelial Cell Hyperplasia in AsthmaR01HL068111 · NHLBI · LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE · PI TESFAIGZI, YOHANNES · 2003 to 2021
$10.9MProteomics of Cardiometabolic and Renal Traits in African AmericansR01HL133870 · NHLBI · UNIVERSITY OF MISSISSIPPI MED CTR · PI ROBERT E GERSZTEN · 2017 to 2026
$6.7MProteomic Pathway Discovery in Cardiovascular DiseaseR01HL132320 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI GERSZTEN, ROBERT E, RAMACHANDRAN, VASAN S · 2016 to 2019
$3.4MBiomarker of Lung Disease in African AmericansR01HL137995 · NHLBI · NATIONAL JEWISH HEALTH · PI BOWLER, RUSSELL PAUL, KECHRIS-MAYS, KATHERINA · 2018 to 2021
$3.4MMulti-omic networks associated with COPD progression in TOPMed CohortsR01HL152735 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI BANAEI-KASHANI, FARNOUSH, BOWLER, RUSSELL PAUL · 2020 to 2023
$3.1MMetabolome and proteome profiles of emphysema and airway diseaseR01HL095432 · NHLBI · NATIONAL JEWISH HEALTH · PI BOWLER, RUSSELL PAUL · 2009 to 2012
$1.6MSphingolipids and inflammatory biomarkers of COPD progression in healthy smokersR01HL129937 · NHLBI · NATIONAL JEWISH HEALTH · PI BOWLER, RUSSELL PAUL · 2015 to 2017
$1.3MOmics Data Integration to Identify Disease Pathways in COPDR21HL140376 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI BANAEI-KASHANI, FARNOUSH, BOWLER, RUSSELL PAUL · 2017 to 2018
$235kNHLBI NIH HHS R01 HL068111NHLBI NIH HHS R01 HL089856NHLBI NIH HHS R01 HL089897NHLBI NIH HHS R01 HL095432NHLBI NIH HHS R01 HL129937NHLBI NIH HHS R01 HL132320NHLBI NIH HHS R01 HL133870NHLBI NIH HHS R01 HL137995NHLBI NIH HHS R01 HL152735NHLBI NIH HHS R21 HL140376NIDDK NIH HHS P30 DK054759NIEHS NIH HHS P30 ES005605
Abstract
PubMed holds no abstract for this paper.
Indexed as
LungPulmonary Disease, Chronic ObstructiveBiomarkersForced Expiratory VolumeHumansProteomicsSpirometryVital CapacityBiomarkersairflow obstructionbiomarkersproteomics
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.